Indexed RV volumes can miss dilation, esp at extremes of body size. In JACC Advances📊, we show that relative RV size (RV/LV volume ratio) improves detection of RV dilation & predicts mortality in TR🫀. 🔗 https://t.co/9GwOVKx7YY @JiwonKimMD @zfalk13 @Tsay_What @WeillCornell

Fantastic @American_Heart scientific statement on best practice for coronary physiological assessment. If you're going to do it, do it correctly. @SripalBangalore @HollandTamis @ACCinTouch https://t.co/ZLis2jNyVx

Drug-eluting Stent, Drug coated balloon or POBA for in-stent coronary restenosis. No difference in DES versus DCB from a Meta-Analysis of RCTs. Will this affect our practice? @SripalBangalore @nkleiman @robertshiuzhang @haisummaqsood https://t.co/Gi2UJutySl

1/ Check out our latest publication in @circintv #circ interventions evaluating DCB, DES, or POBA for in-stent coronary restenosis. https://t.co/YLkD1I4HJV @SripalBangalore @n_kleiman @robertshiuzhang

Big message from #AHA25 #VESALIUS: We do not want to wait until pts have MI or CVA to start aggressive LDL-C lowering! Pts w/ CAD, including by coronary imaging #CAC #CCTA and prior PCI & high risk DM had: 25%⬇️ in CV CHD death/MI/CVA 36%⬇️ in MI w/ addition of PCSK9i 🧵

Lots of people are on dialysis and they die of CV disease #KidneyWk

"Diet, exercise, and smoking cessation are all anti-inflammatory" @Bweber04 👏Great summary of current state of screening and treatment of inflammation @Heart_SCCT @UTSWMedCenter

Deferring Arterial Catheterization in Critically Ill Patients with Shock | New England Journal of Medicine

@NadeenFaza @JGrapsa @JiwonKimMD @ASE360 @iamritu @renujain19 @argulian @purviparwani @JournalASEcho @EGarciaSayan @AguilarMolina_ 📊 Common Sources of Error for Hemodynamic Assessment Factors that can lead to under/overestimation — see table below 👇 #ASEchoJC @ASE360 #Echofirst

@DrKevinBuda @CircAHA @SripalBangalore @PERTConsortium @PERTCouncil @MayoClinicCCM @AnnGageMD @SamHorrMD https://t.co/thej74HS5i @robertshiuzhang @peter_szz @jameshorowitzmd @carlosalviar @SripalBangalore

Outcomes of Percutaneous Mechanical Aspiration in Right-Sided Infective Endocarditis: A Multicenter Registry: @JACCJournals 🥸Percutaneous mechanical aspiration is now in a clinical registry - interesting 😱 Ok here you go 👇👇👇

Results of the SYMPHONY PE IDE trial presented as a late breaker @PERTConsortium and simultaneously published online @CircIntv. A new era in mechanical thrombectomy? @jameshorowitzmd @SVRaoMD @vivianbishay @drandrewsharp @glennfishman https://t.co/VBSOEs91hJ

🚨Great work led by @CardsNYC on identifying "super-responders" to mechanical thrombectomy in acute PE, now in @CircIntv 🔗 https://t.co/hzlKBiQjxH @SripalBangalore @peter_szz @jameshorowitzmd @SamuelB316

New @TheLancet Meta-Analysis by #NelsonWang @BrighamWomens HF Fellow What is the expected BP lowering with various antihypertensive regimens? Robust model derived from n=104,176 pts across 484 RCTs Terrific user-friendly tool: https://t.co/jaWeX3V1fn https://t.co/rdHV0EkEeF

Outcomes with Percutaneous mechanical aspiration for right sided IE. This is one of the largest series even when compared with surgical series. @SVRaoMD @sanjum @drandrewsharp @glennfishman

💡Our commentary in @JAMANetworkOpen highlights findings from a study using Medicare data showing that pregabalin (vs gabapentin💊) carries a ⬆️ risk of incident heart failure. ⚠️Not all gabapentinoids are created equal. @EBirati 🔗 https://t.co/XbojQbitTF

But can it wait on hold for 12 minutes and successfully complete a peer to peer? Or a prior auth for zepbound?

Now in @JACCJournals, we cover the economics of transcatheter interventions. This includes: 1) mechanics of facility & doc payment 2) rapidly evolving CV financial landscape 3) novel research on hospital margins 4) future health econ policy shifts https://t.co/e9lm0IM1EA

Our paper in the August issue of @InvasiveCardiol IVBT is effective for multilayer ISR at 1-year follow up. 🔑 diligent imaging to eval morphology 📷 stepwise lesion prep prior to IVBT delivery. TLR at 1 year 10.9% - slightly improved when compared to previously reported data

Today is #WorldLungCancerDay 🌎🤍 #LungCancerScreening (LCS) looks for lung cancer before symptoms start, when it’s easiest to treat & cure! In this short video (created with @RadiologyInfo_), I’ll walk you through your LCS report— learn what LCS can tell you about your health!

So many feelings! Grateful to amazing collaborators, authors, editors, & others. We are excited for you to read this incredible piece from a vanguard authorship group! A great example of the type of INTERSECTIONS of disciplines and ideas that can stimulate discourse & innovation!